Evaluation of Eudragit® RS-PO and Ethocel® 100 matrices for the controlled release of lobenzarit disodium

Drug Development and Industrial Pharmacy

Volumn 25, Issue 2, 1999, Pages 229-233

  Boza, A ^a   Caraballo, I ^b,c   Alvarez Fuentes, J ^b   Rabasco, A M ^b  

^a Center of Pharmaceutical Chemistry Cuba   (Cuba)

^b UNIVERSITY OF SEVILLE   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETHOCEL 100; ETHYL CELLULOSE; EUDRAGIR RS PO; EUDRAGIT; LOBENZARIT; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; ANTHRANILIC ACID DERIVATIVE; CELLULOSE; DRUG DERIVATIVE; EXCIPIENT; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; RHEUMATOID ARTHRITIS; TABLET COMPRESSION; TABLET FORMULATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; FLOW KINETICS; POWDER; TABLET;

ACRYLIC RESINS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; POLYMERS; POLYMETHACRYLIC ACIDS; POWDERS; RHEOLOGY; TABLETS;

EID: 0032587115     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102164     Document Type: Article

References (14)

1. I. Caraballo, M. Millán and A. M. Rabasco, Pharm. Res., 13, 387 (1996).
2. H. Matsuno, I. Matsushita, K. Kadomaki, H. Tsuji, T. Nakano, and K. Funahashi, Int. J. Immunol., 8, 67 (1992).
3. T. Nakano, Y. Yamashila, Y. Ohsugi, Y. Sugawara, S. Hala, and Y. Takagaki, J. Immunopharmacol., 5, 293 (1983).
4. Y. Ohsugi, T. Nakano, S. I. Hata, R. Niki, T. Matsuno, Y. Nishii, and Y. Takagaki, J. Pharm. Pharmacol., 30, 126 (1978).
5. Japan Pharmaceutical, Medical and Dental Supply, Japan Pharmaceutical Reference, 2nd ed., Author, Tokyo, 1991-1992, p. 82.
6. A. Boza, I. Caraballo, M. J. Fernández-Hervás, J. Alvarez-Fuentes, and A. M. Rabasco, Int. J. Pharm. Adv., 1(4), 429 (1996).
7. A. Boza, G. Jordan, A. Alemán, Y. Herrera, and I. Caraballo, Ciencia Pharmacéutica, 7(3), 107 (1997).
8. J. M. Conrad and J. R. Robinson, Sustained dug release from tablets and particles through coating, in Pharmaceutical Dosage Forms: Tablets, Vol. 3 (H. A. Lieberman and L. Lachman, eds.), Marcel Dekker, New York, 1982, p. 149.
9. M. Fernández-Arévalo, M. T. Vela, and A. M. Rabasco, Drug Dev. Ind. Pharm., 16(2), 295 (1990).
10. A. M. Rabasco, M. A. Holgado, M. Fernández-Arévalo, and J. M. Ginés, Eur. J. Pharm. Biopharm., 37(3), 147 (1991).
11. D. A. Wadke and H. Jacobson, Preformulation testing, in Pharmaceutical Dosage Forms: Tablets, Vol. 1 (H. A. Lieberman and L. Lachman, eds.), Marcel Dekker, New York, 1980, p. 1.
12. J. I. Wells, Pharmaceutical Preformulation: The Physicochemical Properties of Drug Substances, Ellis Horvood, Chichester, 1987, p. 209.
13. I. Caraballo, M. A. Holgado, M. Fernández-Arévalo, M. Millán, A. M. Rabasco, and H. Leuenberger, Drug Dev. Ind. Pharm., 23, 1 (1997).
14. B. Artalejo, A. del Pozo, and C. Fauli, Ind. Farm., 3(4), 103 (1988).